相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Influence of Liver Cirrhosis on the Pharmacokinetics, Pharmacodynamics, and Safety of Tezosentan
Jasper Dingemanse et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Vascular biology and pathobiology of the liver: Report of a single-topic symposium
Yasuko Iwakiri et al.
HEPATOLOGY (2008)
Comparison of the pharmacokinetics, pharmacodynamics and tolerability of tezosentan between caucasian and Japanese subjects
J Dingemanse et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Determination of tezosentan, a parenteral endothelin receptor antagonist, in human plasma by liquid chromatography-tandem mass spectrometry
PLM van Giersbergen et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
In vivo and in vitro disposition profile of tezosentan, an intravenous dual endothelin receptor antagonist, in humans
A Treiber et al.
XENOBIOTICA (2003)
Intrahepatic heterogeneity of hepatic venous pressure gradient in human cirrhosis
S Keiding et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2002)
Entry-into-humans study with tezosentan, an intravenous dual endothelin receptor antagonist
J Dingemanse et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2002)
Receptor- and non-receptor-mediated clearance of big-endothelin and endothelin-1:: differential effects of acute and chronic ETA receptor blockade
M Burkhardt et al.
JOURNAL OF HYPERTENSION (2000)